Nov 19, 2020
Pliant Therapeutics To Participate In The Piper Sandler 32nd Annual Virtual Healthcare Conference
Nov 09, 2020
Pliant Therapeutics to Present Data at The Liver Meeting® 2020
Sep 24, 2020
Pliant Therapeutics Presents Data at American Thoracic Society 2020 Virtual Sessions
Sep 04, 2020
Pliant Therapeutics To Participate In Upcoming Virtual Investor Conferences
Aug 27, 2020
Pliant Therapeutics Presents Data at The Digital International Liver Congress(TM) 2020
Jun 05, 2020
Pliant Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Option to Purchase Additional Shares
Jun 02, 2020
Pliant Therapeutics Announces Pricing of Initial Public Offering
Mar 23, 2020
Pliant Therapeutics Initiates First-in-Human Clinical Trial of PLN-1474 for the Potential Treatment of Liver Fibrosis
Mar 03, 2020
Pliant Therapeutics Raises $100 Million in Series C Financing to Advance Therapies for Fibrotic Diseases
Jan 08, 2020
Pliant Therapeutics Appoints Gayle Crowell to its Board of Directors
Oct 31, 2019
Pliant Therapeutics to Present Preclinical Data in Primary Sclerosing Cholangitis at The Liver Meeting 2019
Oct 23, 2019
Pliant Therapeutics Announces Strategic Collaboration to Develop Novel Therapies for NASH and Fibrotic Diseases
Oct 15, 2019
Pliant Therapeutics Announces Publication Demonstrating Feasibility of Positron Emission Tomography (PET) Tracers for Imaging Fibrosis in Patients with Idiopathic Pulmonary Fibrosis
Jun 27, 2019
Pliant Therapeutics Reports Positive Results of Phase 1b Clinical Study Supporting Advancement of PLN-74809 for Treatment of Idiopathic Pulmonary Fibrosis
Apr 09, 2019
Pliant Therapeutics Reports Positive Results of Phase 1 Clinical Study Support Advancement of PLN-74809 for Idiopathic Pulmonary Fibrosis
Mar 28, 2019
Pliant Therapeutics Presents Data in Human NASH Liver Tissue at The International Liver Congress 2019 Hosted by the European Association for the Study of the Liver (EASL)
Mar 14, 2019
Pliant Therapeutics Appoints Smital Shah to its Board of Directors
Feb 13, 2019
Pliant Therapeutics to Present at Upcoming Investor Conferences
Jan 03, 2019
Pliant Therapeutics Initiates Phase 1 Clinical Study of PLN-74809
Dec 27, 2018
Pliant Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference